Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001104659-23-106378

Director bought 24,670 shares at $13.63 ($336,252)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2023-09-29 Purchase +24,670 $13.63 $336,252 1,928,503 I
Open-market purchases · 24,670 sh · avg $13.63 · $336,252
Loading xslF345X05/tm2327394-1_4seq1.xml…